Cargando…
Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
Proton pump inhibitors are the one of the most widely used drugs in the world. Hypomagnesemic hypoparathyroidism has been reported with different proton pump inhibitors with prolonged oral use. We report the first reported case of possible such effect with intravenous preparation of proton pump inhi...
Autor principal: | Swaminathan, Krishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450563/ https://www.ncbi.nlm.nih.gov/pubmed/26069375 http://dx.doi.org/10.4103/0253-7613.157135 |
Ejemplares similares
-
A hidden history of heartburn: The milk-alkali syndrome
por: Swaminathan, Krishnan
Publicado: (2011) -
The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study
por: Chacko, Jithin, et al.
Publicado: (2021) -
Is there a place for angiotensin receptor-neprilysin inhibitors in the treatment of heart failure patients after heart transplantation?
por: Gulin, Dario, et al.
Publicado: (2019) -
Acebrophylline-induced angioedema
por: Kuriachan, Sanitha, et al.
Publicado: (2015) -
Sitagliptin-induced hemolysis
por: Bekur, Ragini, et al.
Publicado: (2010)